2-Butenoic acid, 4-[[(5a,6b)-4,5-epoxy-3,14-dihydroxy-17-methylmorphinan-6-yl]amino]-14-hydroxy-4-oxo-,methyl ester, (2E)- (9CI) (72782-06-0)

Identification
Name:	2-Butenoic acid, 4-[[(5a,6b)-4,5-epoxy-3,14-dihydroxy-17-methylmorphinan-6-yl]amino]-14-hydroxy-4-oxo-,methyl ester, (2E)- (9CI)
Synonyms:	Morphinan,2-butenoic acid deriv.
CAS:	72782-06-0
Molecular Formula:	C22H26 N2 O6
Molecular Weight:	0
InChI:	InChI=1/C22H26N2O6/c1-24-10-9-21-18-12-3-4-14(25)19(18)30-20(21)13(7-8-22(21,28)15(24)11-12)23-16(26)5-6-17(27)29-2/h3-6,13,15,20,25,28H,7-11H2,1-2H3,(H,23,26)/b6-5+/t13-,15?,20+,21+,22-/m1/s1
Molecular Structure:
Properties
Flash Point:	354.3°C
Boiling Point:	662.2°C at 760 mmHg
Density:	1.45g/cm³
Refractive index:	1.671
Flash Point:	354.3°C
Safety Data

Other Product

2-Butenoic acid, 4-[[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-,methyl ester, (2E)-
2-Butenoic acid,4-[[(5R)-17-(cyclopropylmethyl)- 4,5-epoxy-3-hydroxy-6- oxomorphinan-14-yl]amino]-4-oxo-,methyl ester
2-Butenoic acid, 4-[[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-,methyl ester, hydrochloride (1:1), (2E)-
2-Propenamide,3-(4-chlorophenyl)-N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-, (2E)-
Morphinan-6-one,17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-3-methoxy-, [(5a)-4,5-epoxy-3,14-dihydroxy-17-methylmorphinan-6-ylidene]hydrazone,(5a)- (9CI)
Benzenepropanamide,4-chloro-N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-(9CI)
2-Butenoicacid, 4-[[[(5a,7a)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-6,14-ethenomorphinan-7-yl]methyl]amino]-4-oxo-,methyl ester, (2E)- (9CI)
Acetamide,2-bromo-N-[(5a)-4,5-epoxy-3-hydroxy-17-methyl-6-oxomorphinan-14-yl]-(9CI)
Acetamide, N-[(5a)-4,5-epoxy-3-hydroxy-17-methyl-6-oxomorphinan-14-yl]-2-mercapto-(9CI)
2-Butenoic acid,4-[[(5R,7R)-17-(cyclopropylmethyl)- 4,5-epoxy-18,19-dihydro-3- hydroxy-6-methoxy-6,14-ethenomorphinan- 7-yl]amino]-4-oxo-,methyl ester,(2E)-
2-Butenoic acid, 4-[[(5a,6a)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-,methyl ester, (E)- (9CI)
Benzeneacetamide,5-azido-N-[(5a)-4,5-epoxy-3-hydroxy-17-methyl-6-oxomorphinan-14-yl]-2-nitro-(9CI)
Morphinan-6-one,14-[[3-(4-chlorophenyl)propyl]amino]-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-,(5a)- (9CI)
b-D-Glucopyranosiduronic acid, (5a)-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-6-oxomorphinan-3-yl(9CI)
Acetamide,2-bromo-N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-(9CI)
Acetamide, N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-2-mercapto-(9CI)
Morphinan-?17-?carboxaldehyde, 4,?5-?epoxy-?3,?14-?dihydroxy-?6-?oxo-?, (5α)?-
b-D-Glucopyranosiduronic acid, (5a)-4,5-epoxy-14-hydroxy-17-methyl-6-oxomorphinan-3-yl
b-D-Glucopyranosiduronic acid, (5a)-4,5-epoxy-14-hydroxy-6-oxo-17-(2-propenyl)morphinan-3-yl
Spiro[imidazolidine-4,6'-morphinan]-2,5-dione,4',5'-epoxy-3',14'-dihydroxy-17'-methyl-, (5'a,6'a)- (9CI)